A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Chemotherapy
Related studies linked through entity extraction aliases.
Study of Adebrelimab Combined With Thymalfasin and Chemotherapy for Neoadjuvant Treatment of Esophageal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Shuganhuazhuo Formula for Advanced Hepatocellular Carcinoma With Damp-Heat Syndrome
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Trial of DN022150 Versus Chemotherapy in Previously Treated Advanced Pancreatic Cancer With KRAS G12D Mutation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Optimal Application Timing of ADC Drugs for Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Safety and Efficacy of Ubamatamab With First-line Chemotherapy in Ovarian Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Camrelizumab Combined With Famitinib Malate and Chemotherapy for Treatment of Recurrent/ Metastatic Cervical Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Laser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent Glioblastomas
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Negative/Low Hormone Receptor and APOcrine Lobular Invasive Breast Carcinoma - A Real-World International Cohort Study
- Status
- RECRUITING
- Phase
- N/A
TACE Combined With Thermal Ablation and ADC, PD-1, and Chemotherapy as First-line Treatment for HER2-highly-expressing Gastric Cancer With Liver Metastases: A Multicenter, Single-arm Prospective Clinical Study.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of 9MW2821 Versus Chemotherapy in Participants With Previously Treated Locally Advanced or Metastatic Triple-Negative Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Vebreltinib Plus Chemotherapy as First-line Treatment for MET-overexpressing NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Neoadjuvant SHR-A1811 Combined With Pertuzumab in HER2-Positive Breast Cancer: An Exploratory Clinical Study.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Neo-CRT Plus Serplulimab, Nimotuzumab in Patients With Locally Advanced Resectable ESCC
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Iparomlimab and Tuvonralimab Plus Hypofractionated Radiotherapy and Chemotherapy for HAHNSCC
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Adebrelimab Plus Chemotherapy for Esophageal Cancer: A Clinical Study
- Status
- RECRUITING
- Phase
- PHASE2
ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3